VIEWPOINTS

Partnerships in biomolecular research: the EMBL paradigm

An interview with the Director of International Relations at EMBL on the institute's plans about establishing strong partnerships accross Europe and the world.
Published
Go to the profile of Maria Papatriantafyllou
Maria Papatriantafyllou
Editorial Manager, Molecular Oncology
Partnerships in biomolecular research: the EMBL paradigm
Go to the profile of Carolyn Elliss
Go to the profile of Isabel Varela Nieto
Go to the profile of The FEBS Journal

In an era when application of cutting-edge technologies on a large scale enables the production and processing of massive biological datasets, cooperation among Research Institutes and beyond seems to be the only way to go. European Science policy and European Research Institutes alike are developing strategies to achieve this goal.

The latest Scientists' Forum article from FEBS Letters, presents the views of Dr. Silke Schumacher, Director International Relations at EMBL, on establishing strong research alliances across Europe and the world.


Read more:

Papatriantafyllou, M. (2017), Partnerships in European biomolecular research: the EMBL paradigm. FEBS Lett. doi:10.1002/1873-3468.12926

Go to the profile of Maria Papatriantafyllou
Maria Papatriantafyllou
Editorial Manager, Molecular Oncology
A series of coincidences brought about to my young post-doc self a revelation: my ideal career should combine editorial work and science communication. While working as an Editor on FEBS Press and, before that, on Nature Reviews journals, I have immensely enjoyed communicating with Life Science Researchers — be it on past, current and emerging topics in biological research, or on the future of Science Policy and Publishing.

Recommended Content